📈 Economy · Next Week

AstraZeneca plc (NASDAQ: AZN) beats Q2 2026 core EPS consensus of approx. USD 2.50 per ADS (July 27, 2026)

Hit ✦ AI-generated prediction Published on 22. July 2026 · Predicted for 27. July 2026 · Based on: Historical Cycle

Probability

70%

AstraZeneca reports Q2 2026 results on July 27, 2026. Consensus from 35 analysts stands at USD 2.50/ADS (Defense World); some sources cite up to USD 2.60. Q1 2026 core EPS was USD 2.58 (consensus: USD 2.52, beat: +USD 0.06). AZN reconfirmed FY2026 guidance for low double-digit core EPS growth at CER — a strong forward signal. Growth drivers: Tagrisso, Enhertu, Lynparza, and emerging CVRM franchise. AZN has beaten consensus in 4 of the last 5 quarters. Headwind: minor consensus reduction by Erste Group Bank on July 22, 2026.

Data basis for this prediction

AZN Q2 2026 EPS-Konsens: 2,50 USD/ADS (35 Analysten, 83 % Buy) – Defense World (20.07.2026)
AZN Q1 2026: Kern-EPS 2,58 USD vs. Konsens 2,52 USD (+0,06 USD) – BusinessWire (28.04.2026)
AZN FY2026-Guidance: Kern-EPS-Wachstum niedriges zweistelliges % (CER) – MarketScreener (Juli 2026)
Erste Group Bank senkt AZN FY2026-EPS-Prognose leicht – The Markets Daily (22.07.2026)

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit

[Vorzeitig entschieden] AstraZeneca meldete Q2-2026-Core-EPS von 2,63 USD je ADS – deutlich über dem Konsens von ca. 2,50 USD. Quelle: finance.yahoo.com, stocktitan.net ('AstraZeneca H1 Results: Core EPS Up 12%').

Related Predictions

📈 Economy ✦ AI

S&P 500 (^GSPC) closes above 7,450 points on 30 September 2026 (confirmed by NYSE closing price or Bloomberg by 30 September 2026)

The S&P 500 closed at 7,636.36 on 9 September 2026. Falling below 7,450 by month-end would require a 2.4% decline. Headwinds: Fed rate hike of 25bp on 16 September (CentralBank.Watch: 59% probability), August PPI above expectations (+5.4% YoY), Iran-Gulf risk premium. Stabilizing factors: hike largely priced in (Polymarket: 93% for zero 2026 cuts), Q2 earnings solid, no recession signals. Historically, a single 25bp September hike rarely causes a monthly decline above 2.5%.

73%

Next Month · Predicted for 30. Sep 2026

📈 Economy ✦ AI

US Federal Reserve raises the Federal Funds target range by 25 basis points on 16 September 2026 (FOMC decision)

Polymarket shows a 53% probability for a 25 basis point hike as of September 10, 2026. US Core CPI August 2026 (release September 11) is expected by market consensus to be above 3.0% YoY. The ECB raised its deposit rate by 25 bps to 2.50% on September 10, 2026 – an inflation-fighting signal that provides cover for the Fed. Against a hike: a mild slowdown in US industrial output. CME FedWatch also shows ~53% probability for a hike.

53%

Next Week · Predicted for 16. Sep 2026

📈 Economy ✦ AI

DAX 40 (XETRA) closes above 26,000 points on 30 September 2026 (confirmed by XETRA closing price or Bloomberg by 30 September 2026)

The DAX closed at 25,562 points on September 9, 2026. A gain of +1.7% is required by month-end. Headwinds: ECB rate hike to 2.50% (September 10), 53% FOMC hike probability (September 16), persistently high oil prices (~$101/barrel Brent) weigh on energy-intensive DAX heavyweights. Tailwinds: strong SAP cloud growth expected, robust US demand, EUR/USD at 1.1644 benefits exporters. Implied 30-day volatility (VDAX): ~16%, corresponding to a σ range of roughly ±5.5% by month-end — the 26,000 level falls within the central distribution.

48%

Next Month · Predicted for 30. Sep 2026